CRISPR

CRISPR1-tapt1b

ID
ZDB-CRISPR-161026-1
Name
CRISPR1-tapt1b
Previous Names
None
Target
Sequence
5' - GACAGTGTGTCCAGGAGGAT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
cmg6 tapt1b
Expression
Gene expression in Wild Types + CRISPR1-tapt1b
No data available
Phenotype
Phenotype resulting from CRISPR1-tapt1b
Phenotype of all Fish created by or utilizing CRISPR1-tapt1b
Phenotype Fish Conditions Figures
eye melanocyte spatial pattern, abnormal tapt1bcmg6/cmg6 (AB) standard conditions Fig. S4 from Jarayseh et al., 2023
eye iridophore spatial pattern, abnormal tapt1bcmg6/cmg6 (AB) standard conditions Fig. S4 from Jarayseh et al., 2023
cranial cartilage malformed, abnormal AB + CRISPR1-tapt1b standard conditions Fig. S13 from Symoens et al., 2015
ceratobranchial cartilage disorganized, abnormal AB + CRISPR1-tapt1b standard conditions Fig. S13 from Symoens et al., 2015
ceratohyal cartilage disorganized, abnormal AB + CRISPR1-tapt1b standard conditions Fig. S13 from Symoens et al., 2015
splanchnocranium immature, abnormal AB + CRISPR1-tapt1b standard conditions Fig. S13 from Symoens et al., 2015
ceratobranchial cartilage chondrocyte absent, abnormal hu5910Tg + CRISPR1-tapt1b standard conditions Fig. S13 from Symoens et al., 2015
cranial neural crest cell decreased amount, abnormal y1Tg + CRISPR1-tapt1b standard conditions Fig. S13 from Symoens et al., 2015
cranial neural crest cell disorganized, abnormal y1Tg + CRISPR1-tapt1b standard conditions Fig. S13 from Symoens et al., 2015
whole organism increased length, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 2 from Jarayseh et al., 2023
kidney dorsal side increased pigmentation, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 2 from Jarayseh et al., 2023
ciliary marginal zone ventral side decreased size, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
swimming behavior process quality, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 5 from Jarayseh et al., 2023
oral cavity dorsal side increased pigmentation, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 2 from Jarayseh et al., 2023
swim bladder dorsal side increased pigmentation, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 2 from Jarayseh et al., 2023
retina increased thickness, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
anterior chamber eye collapsed, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
retinal inner plexiform layer inclusion body present, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
retinal ganglion cell layer hyperplastic, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
pupil decreased area, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 3 from Jarayseh et al., 2023
dorsal aorta dorsal side increased pigmentation, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 2 from Jarayseh et al., 2023
retinal ganglion cell layer increased thickness, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
eye melanocyte spatial pattern, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 2 from Jarayseh et al., 2023
ciliary marginal zone dorsal side decreased size, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
lens capsule delaminated, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
photoreceptor outer segment layer degenerate, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
retinal inner plexiform layer increased thickness, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
lens decreased size, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
whole organism opn1mw2 expression increased amount, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 7 from Jarayseh et al., 2023
whole organism mipa expression decreased amount, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 7 from Jarayseh et al., 2023
whole organism timp2b expression increased amount, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 7 from Jarayseh et al., 2023
retinal inner plexiform layer hyperplastic, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
integument increased pigmentation, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 2 from Jarayseh et al., 2023
whole organism cryaa expression decreased amount, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 7 from Jarayseh et al., 2023
whole organism dead, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. S2 from Jarayseh et al., 2023
lens cell mislocalised, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
whole organism crygn1 expression decreased amount, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 7 from Jarayseh et al., 2023
eye iridophore spatial pattern, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 2 from Jarayseh et al., 2023
anterior chamber eye opacity, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
vitreous absence of anatomical entity, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
retinal pigmented epithelium low brightness, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
eye decreased area, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 3 from Jarayseh et al., 2023
lens position, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 4 from Jarayseh et al., 2023
pupil decreased ratio eye, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 3 from Jarayseh et al., 2023
optokinetic behavior decreased process quality, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 5 from Jarayseh et al., 2023
whole organism col2a1a expression increased amount, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 7 from Jarayseh et al., 2023
whole organism rom1a expression decreased amount, abnormal tapt1acmg3/cmg3; tapt1bcmg6/cmg6 (AB) standard conditions Fig. 7 from Jarayseh et al., 2023
Citations